NICE published guidelines on the management of atrial fibrillation (AF) in 2014\. The following is also based on the joint American Heart Association (AHA), American College of Cardiology (ACC) and European Society of Cardiology (ESC) 2016 guidelines  
  
Agents with proven efficacy in the pharmacological cardioversion of atrial fibrillation  
* amiodarone
* flecainide (if no structural heart disease)
* others (less commonly used in UK): quinidine, dofetilide, ibutilide, propafenone

  
Less effective agents  
* beta\-blockers (including sotalol)
* calcium channel blockers
* digoxin
* disopyramide
* procainamide
